NCT03754582View on ClinicalTrials.gov

A Study of Intravenous Perampanel in Japanese Participants With Epilepsy

PHASE2CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

November 27, 2018

Primary Completion Date

December 10, 2019

Study Completion Date

December 10, 2019

Conditions
EpilepsySeizures
Interventions
DRUG

Perampanel

Oral tablets.

DRUG

Perampanel

Intravenous infusion.

Trial Locations (13)

Unknown

Eisai trial site 5, Kurume

Eisai trial site 12, Sapporo

Eisai trial site 9, Ōmura

Eisai trial site 7, Sayama

Eisai trial site 2, Asaka

Eisai trial site 13, Hamamatsu

Eisai trial site 8, Kodaira

Eisai trial site 10, Hiroshima

Eisai trial site 6, Kagoshima

Eisai trial site 1, Niigata

Eisai trial site 11, Okayama

Eisai trial site 3, Shizuoka

Eisai trial site 4, Yamagata

All Listed Sponsors
lead

Eisai Co., Ltd.

INDUSTRY

NCT03754582 - A Study of Intravenous Perampanel in Japanese Participants With Epilepsy | Biotech Hunter | Biotech Hunter